New York just opened its door to Bitcoin financial services. Strike secured a BitLicense from the state’s Department of Financial Services, bringing Bitcoin tradingNew York just opened its door to Bitcoin financial services. Strike secured a BitLicense from the state’s Department of Financial Services, bringing Bitcoin trading

Best Crypto Presales 2026: Strike Wins New York BitLicense as Pepeto, ZKP, Bitcoin Hyper and BlockDAG Battle for the Top Spot

2026/03/07 13:22
5 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

New York just opened its door to Bitcoin financial services. Strike secured a BitLicense from the state’s Department of Financial Services, bringing Bitcoin trading and bill payment to millions of residents who had no access before. When regulated access expands like this, fresh capital enters the market. And that capital looks for the best crypto presales 2026 has to offer. Here is where the serious options stand.

Strike secures New York BitLicense bringing Bitcoin financial services to 8 million state adults

The New York State Department of Financial Services granted Strike a BitLicense, authorizing it to offer Bitcoin custody, trading, and bill payment products to New York residents for the first time. According to CoinDesk, NYDFS approval is among the toughest regulatory clearances in the US crypto space, making Strike’s license a strong signal of compliance credibility. New York’s roughly 8 million adults now have regulated access to Bitcoin services from a company that has built its infrastructure specifically for that purpose. When institutional pipelines into crypto widen at the state level, the downstream effect touches the entire presale market, as new capital searches for early entry points before exchange discovery begins.

Best Crypto Presales 2026: Strike Wins New York BitLicense as Pepeto, ZKP, Bitcoin Hyper and BlockDAG Battle for the Top Spot

1. ZKP and its demand driven auction structure

Zero Knowledge Proof attracts analyst attention because of how its presale auction works. Rather than fixed pricing, ZKP uses a demand responsive model where each stage reduces daily token allocation, currently at 190 million tokens per day dropping to 180 million in the next phase. According to CoinMarketCap, the project has secured $1.75 million in early funding and advanced to stage two of its presale. The combination of shrinking supply alongside rising participation creates mathematical conditions that analysts associate with fast price discovery at listing. Some observers project the auction could reach $1.7 billion before closing, though exact timelines depend on how quickly each stage fills.

2. Pepeto and the three product infrastructure no meme coin presale has ever built

This is the thing about the best crypto presales 2026 has produced so far. Most of them have one angle. A technology story. A payment narrative. A DeFi pitch. Pepeto has something none of them have: three products from the founders who already proved the model works at $7 billion.

PepetoSwap, a cross chain bridge, and a full trading exchange are all announced by the team and approaching launch together. Dual audits from SolidProof and Coinsult returned zero vulnerabilities. $7.391 million raised at $0.000000186. The 537x return target at $0.0001 is not a prediction. It is the gap between where you can enter today and where the listing price is set.

A $115 investment at presale prices targets $61,755 at the 537x listing price. ZKP is interesting. Bitcoin Hyper has an infrastructure story. BlockDAG listed. But Pepeto is the only presale in this cycle where PEPE founders, three DeFi products approaching launch, and a seven figure bear market raise all converge at a single presale entry point. That is what makes it the standout among the best crypto presales 2026 has on offer.

3. Bitcoin Hyper and the long infrastructure play

Bitcoin Hyper targets Bitcoin Layer 2 scaling, aiming to add smart contract functionality and faster settlement to BTC’s base layer. The project has raised over $31.2 million from investors with longer time horizons who believe Bitcoin’s programmability story will play out across the full cycle. Analysts tracking Bitcoin Hyper frame it as a measured growth play rather than a fast multiplier, with year end forecasts that reflect the pace of infrastructure development rather than speculative momentum.

Pepeto stands above all best crypto presales 2026 entries when products and founders align

Strike opening New York to Bitcoin services, ZKP running a demand driven auction, Bitcoin Hyper targeting Layer 2 infrastructure, BlockDAG post listing watching adoption. All of these are active stories. Pepeto is the only one where the story already worked once at seven billion dollars and is now backed by three DeFi products approaching launch simultaneously. The best crypto presales 2026 produces rarely offer this combination. Pepeto does.

Click To Visit Pepeto Website To Enter The Presale

FAQs

What are the best crypto presales to buy in 2026?

The best crypto presales in 2026 include Pepeto, which stands out with $7.391 million raised at $0.000000186, a 537x return target at $0.0001, three DeFi products approaching launch from the PEPE founders, and dual zero vulnerability audits from SolidProof and Coinsult. No other presale in this cycle combines proven founders, multiple product launches, and seven figure bear market capital this way.

How do I compare crypto presales in 2026 to find the best entry?

Comparing crypto presales in 2026 requires checking four things: founder track record, independently audited smart contracts, product development stage, and capital raised under adverse conditions. Pepeto scores highest on all four, with PEPE founders, SolidProof and Coinsult dual audits with zero vulnerabilities, three products approaching launch, and $7.391 million raised during extreme market fear.

Is ZKP a good crypto presale investment in 2026?

ZKP is a credible presale with a demand driven auction structure and $1.75 million raised in stage two, with daily token allocation shrinking as each phase advances. For investors seeking stronger return potential, Pepeto at $0.000000186 with a 537x return target and three DeFi products approaching launch from proven PEPE founders offers more asymmetric upside in the same 2026 cycle.

Comments
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09